Portola Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Oct 03, 2017 20:05 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Oct. 03, 2017 -- Portola Pharmaceuticals, Inc.® (NASDAQ:PTLA) announced today that on September 27, 2017, the Compensation Committee of the Board of Directors approved, effective as of...
Teekay LNG Partners Declares Distribution
Oct 03, 2017 20:05 pm UTC| Business
HAMILTON, Bermuda, Oct. 03, 2017 -- Teekay GP LLC, the general partner of Teekay LNG Partners L.P. (Teekay LNG or the Partnership) (NYSE:TGP), has declared a cash distribution of $0.14 per unit for the quarter ended...
Teekay Corporation Declares Dividend
Oct 03, 2017 20:05 pm UTC| Business
HAMILTON, Bermuda, Oct. 03, 2017 -- Teekay Corporation (Teekay or the Company) (NYSE:TK) announced that its Board of Directors has declared a cash dividend on its common stock of $0.055 per share for the quarter ended...
Teekay Offshore Partners Declares Distributions on Series A and B Preferred Units
Oct 03, 2017 20:05 pm UTC| Business
HAMILTON, Bermuda, Oct. 03, 2017 -- Teekay Offshore GP LLC, the general partner of Teekay Offshore Partners L.P. (Teekay Offshore or the Partnership) (NYSE:TOO), has declared the following distributions for the period...
Teekay Offshore Partners Declares Distribution
Oct 03, 2017 20:05 pm UTC| Business
HAMILTON, Bermuda, Oct. 03, 2017 -- Teekay Offshore GP LLC, the general partner of Teekay Offshore Partners L.P. (Teekay Offshore or the Partnership) (NYSE:TOO), has declared a distribution of $0.01 per unit for the...
EPAM Announces Date for Third Quarter 2017 Earnings Release and Conference Call
Oct 03, 2017 20:05 pm UTC| Business
NEWTOWN, Pa., Oct. 03, 2017 -- EPAM Systems, Inc. (NYSE:EPAM) will host a conference call at 8:00 a.m. EDT on Thursday, November 2, 2017 to discuss its third quarter 2017 financial results. A news release containing...
Strongbridge Biopharma plc Announces Proposed Public Offering of Ordinary Shares
Oct 03, 2017 20:02 pm UTC| Business
DUBLIN, Ireland and TREVOSE, Pa., Oct. 03, 2017 -- Strongbridge Biopharma plc (NASDAQ:SBBP) (the “Company”) today announced that it intends to offer and sell its ordinary shares in an underwritten public offering. The...